Kactus Biosystems

Kactus Biosystems is a cutting-edge biotech company focused on research and development in the fields of immunotherapy, cell and gene therapy, and mRNA treatments. The company operates in the global innovation drug research and development market, providing key protein enzymes for structural design. Kactus Biosystems serves clients that are primarily global innovation drug research and development enterprises, addressing common issues in the protein market such as low success rates and long development periods. The company has developed an exclusive functional repromotion protein and high-activity protein-based R&D platform to overcome these challenges. Kactus Biosystems generates revenue by offering high-quality protein expression services and selling recombinant protein products that maintain high activity levels in cell function assays. The company has successfully completed multiple rounds of financing, including a $30 million Pre-A round and a 40 million yuan A round, demonstrating strong investor confidence.

Keywords: biotech, immunotherapy, cell therapy, gene therapy, mRNA treatments, protein enzymes, structural design, recombinant protein, high-activity, global innovation.